Citation tools

Yun, Jung-A et al "N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases." Molecular Pharmacology 96.6 (2019): 692-701. Web. 26 Feb. 2021.